Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes - Pérez MS; Rodríguez-Capitán J; Requena-Ibáñez JA; Santos-Gallego CG; Urooj Zafar M; Escolar G; Mancini D; Mitter S; Lam D; Contreras JP; Fergus I; Atallah-Lajam F; et al. (CARDIOVASCULAR DRUGS AND THERAPY, 2025)